Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charleen Oligo"'
Autor:
Abire Jedidi, Jean-Luc Villeval, Charleen Oligo, William Vainchenker, Nicole Casadevall, Laurence Jeanson-Leh, Anne Galy, Jean-Antoine Ribeil, Caroline Marty
Publikováno v:
Blood. 114:1842-1851
The JAKV617F mutation is responsible for the majority of breakpoint cluster region (BCR)/Abelson (ABL)–negative myeloproliferative disorders. Ongoing clinical trials of Janus kinase 2 (JAK2) inhibitors in myeloproliferative disorder patients use sm
Publikováno v:
Stroke. 36(5)
Background and Purpose— Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited small vessel disease causing stroke and dementia. The disease is caused by highly stereotyped mutations in
Autor:
Florence Meyer-Losic, Simon P. Newman, Pierre Roubert, Atul Purohit, Mark Carlson, M P Leese, Paul A. Foster, Ann Fiore, Charleen Oligo, Laurent Vignaux, Jeffrey Lauer, Hervé Gaudry, Philip G. Kasprzyk, Sonia Bernetiere
Publikováno v:
Cancer Research. 72:2795-2795
STX-140 is an anti-tubulin binding agent which has demonstrated a good anti-tumor efficacy profile. Although the binding site on tubulin differs from other classical tubulin binders, one could anticipate the same type of safety issues with such an ag
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 25:S699-S699